Understanding your genetic predisposition to GLP-1 sensitivity allows PlexusDx providers to choose the most compatible medication (semaglutide injection, oral tirzepatide, or GLP-Squared combinations) and recommend a titration schedule that minimizes neurochemical disruption
But dont be surprised if your provider recommends switching later on
b Designed for you and your patients Flexible ways to pay Delivered to your patient's home Patients can arrange their shipments according to their schedule
However, it should not be viewed as a stand-alone or miraculous solution
Novo was first in the market,got CMS Medicare approval with Narrow Pipeline of Drugs only on Weight loss & Diabetes (Front runner Semaglutide) Lilly has better Efficacy Drug(Tirzepatide & Pipeline drugs) for Wt loss/Diabetes,Longer IP Patent Runway till mid 2030s with better Growth Penetration With Wider Pipeline of Pharma drugs including Oncology/ Neurology/ Immunology/ Inflammation,Urology- Erectile Dysfunction,Osteoporosis in Men and Women and afford to run the price war with Novo and wipeout their Business Eli Lilly is winning hands down
Glutamine fuels immune cells like lymphocytes and macrophages, which are your bodys first line of defense against infection